Patents Assigned to Horacio Url Saragovi
  • Anti-ganglioside compound for targeting cancer and generating antibodies
    Patent number: 10363305
    Abstract: It is provided a multivalent ganglioside carbohydrate as a therapeutic cancer vaccine. The GD2 and GD3 carbohydrate conjugated disclosed are linked by a spacer to form a multimer which conserves the native structural feature of naturally occurring GD2 or GD3, the tetramer being immunogenic and elicits cytotoxic anti-gangliosides humoral and cellular responses in vivo.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: July 30, 2019
    Assignee: Horacio Url Saragovi
    Inventors: Horacio Uri Saragovi, Wenyong Tong